Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

CRO Sundia Identifies Four Pre-Clinical Candidates for Xcovery

publication date: Feb 10, 2009

Sundia MediTech (桑迪亚医药技术（上海）有限公司), a Shanghai-based CRO, and Xcovery of Florida reported that their two-year drug discovery collaboration has yielded four pre-clinical candidates, with two more that could be identified in the next three months. The results far surpassed the original timetable. Xcovery, a recent spin-off of The Scripps Research Institute, is focused on next-generation kinase therapeutics that will seek to treat inflammation and cancer. More details...



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital